Edinburgh, United Kingdom · Founded 2018 · Privately Held (backing)
Developer of a complementary-regulating therapy platform designed to mitigate harmful immune responses in extracorporeal medical procedures. Invizius is based in Edinburgh, United Kingdom and was founded in 2018. Its last reported valuation was $47.8 million in Jun 2026. It has raised $18.7 million.
Last reported valuation
$47.8M
Oct 2026
Priced at
—
Total raised
$18.7M
Last round
—
Cap table — not yet on record
Invizius's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Invizius with a free account
·The complete investor list: 18 names
·Watch Invizius: the Monday email on marks, rounds and moves
